Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.147x

Based on the latest financial reports, Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.25 Billion ≈ $183.09 Million USD) by net assets (CN¥8.50 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Starlake Bioscience Co Inc Zhaoqing Guan stock valuation for the company's overall valuation and market capitalisation.

Starlake Bioscience Co Inc Zhaoqing Guangdong - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Starlake Bioscience Co Inc Zhaoqing Guangdong's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Starlake Bioscience Co Inc Zhaoqing Guangdong Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Starlake Bioscience Co Inc Zhaoqing Guangdong ranked by their cash flow conversion efficiency. Explore how high is Starlake Bioscience Co Inc Zhaoqing Guan's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Waypoint REIT AU:WPR	0.029x
Yindu Kitchen Equipment Co Ltd SHG:603277	0.076x
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	0.004x
NCR Voyix Corporation NYSE:VYX	0.052x
Jiangsu Chengxing Phosph-Chemical Co Ltd SHG:600078	0.150x
CTS International Logistics Corp Ltd SHG:603128	0.000x
Black Peony Group Co Ltd SHG:600510	0.000x
Elecon Engineering Company Limited NSE:ELECON	0.072x

Annual Cash Flow Conversion Efficiency for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)

The table below shows the annual cash flow conversion efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. View 600866 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.45 Billion ≈ $1.24 Billion	CN¥1.29 Billion ≈ $189.06 Million	0.153x	-48.80%
2024-12-31	CN¥8.03 Billion ≈ $1.18 Billion	CN¥2.40 Billion ≈ $350.87 Million	0.299x	+12.86%
2023-12-31	CN¥7.66 Billion ≈ $1.12 Billion	CN¥2.03 Billion ≈ $296.48 Million	0.265x	+10.25%
2022-12-31	CN¥6.93 Billion ≈ $1.01 Billion	CN¥1.66 Billion ≈ $243.28 Million	0.240x	+121.16%
2021-12-31	CN¥1.78 Billion ≈ $259.83 Million	CN¥192.63 Million ≈ $28.19 Million	0.108x	-27.57%
2020-12-31	CN¥1.67 Billion ≈ $244.23 Million	CN¥249.99 Million ≈ $36.58 Million	0.150x	+6.82%
2019-12-31	CN¥1.52 Billion ≈ $222.47 Million	CN¥213.17 Million ≈ $31.19 Million	0.140x	+164.58%
2018-12-31	CN¥956.42 Million ≈ $139.95 Million	CN¥50.69 Million ≈ $7.42 Million	0.053x	+20.96%
2017-12-31	CN¥914.14 Million ≈ $133.77 Million	CN¥40.05 Million ≈ $5.86 Million	0.044x	+14.12%
2016-12-31	CN¥1.07 Billion ≈ $156.93 Million	CN¥41.17 Million ≈ $6.02 Million	0.038x	+1365.65%
2015-12-31	CN¥1.05 Billion ≈ $153.37 Million	CN¥2.75 Million ≈ $401.72K	0.003x	+119.01%
2014-12-31	CN¥1.47 Billion ≈ $214.84 Million	CN¥-20.22 Million ≈ $-2.96 Million	-0.014x	+28.32%
2013-12-31	CN¥1.47 Billion ≈ $214.44 Million	CN¥-28.16 Million ≈ $-4.12 Million	-0.019x	+88.62%
2012-12-31	CN¥1.63 Billion ≈ $239.18 Million	CN¥-276.02 Million ≈ $-40.39 Million	-0.169x	-561.92%
2011-12-31	CN¥1.80 Billion ≈ $263.72 Million	CN¥65.88 Million ≈ $9.64 Million	0.037x	-43.78%
2010-12-31	CN¥1.61 Billion ≈ $235.47 Million	CN¥104.63 Million ≈ $15.31 Million	0.065x	-79.05%
2009-12-31	CN¥1.02 Billion ≈ $149.30 Million	CN¥316.73 Million ≈ $46.35 Million	0.310x	+61.84%
2008-12-31	CN¥776.46 Million ≈ $113.62 Million	CN¥148.93 Million ≈ $21.79 Million	0.192x	+72.98%
2007-12-31	CN¥742.02 Million ≈ $108.58 Million	CN¥82.28 Million ≈ $12.04 Million	0.111x	+181.49%
2006-12-31	CN¥892.18 Million ≈ $130.55 Million	CN¥35.14 Million ≈ $5.14 Million	0.039x	-26.41%
2005-12-31	CN¥874.86 Million ≈ $128.02 Million	CN¥46.83 Million ≈ $6.85 Million	0.054x	+64.59%
2004-12-31	CN¥893.38 Million ≈ $130.73 Million	CN¥29.05 Million ≈ $4.25 Million	0.033x	-80.35%
2003-12-31	CN¥904.58 Million ≈ $132.37 Million	CN¥149.70 Million ≈ $21.91 Million	0.165x	-24.57%
2002-12-31	CN¥834.94 Million ≈ $122.18 Million	CN¥183.18 Million ≈ $26.81 Million	0.219x	+172.54%
2001-12-31	CN¥755.58 Million ≈ $110.57 Million	CN¥60.82 Million ≈ $8.90 Million	0.081x	-35.25%
2000-12-31	CN¥751.40 Million ≈ $109.95 Million	CN¥93.41 Million ≈ $13.67 Million	0.124x	+65.11%
1999-12-31	CN¥703.50 Million ≈ $102.94 Million	CN¥52.97 Million ≈ $7.75 Million	0.075x	-52.56%
1998-12-31	CN¥448.25 Million ≈ $65.59 Million	CN¥71.14 Million ≈ $10.41 Million	0.159x	--

About Starlake Bioscience Co Inc Zhaoqing Guangdong

SHG:600866 China Biotechnology

Market Cap

$1.02 Billion

CN¥6.98 Billion CNY

Market Cap Rank

#8896 Global

#2183 in China

Share Price

CN¥4.20

Change (1 day)

-0.71%

52-Week Range

CN¥4.06 - CN¥8.13

All Time High

CN¥9.46